“…If this is the case, then soybean oil-based emulsions (eg, Intralipid or Diprivan, formulated as an emulsion of 1% propofol, 10% soybean oil, and 1.2% purified egg phospholipid) perhaps should not be given to acutely ill patients. 9,19 Apart from the recommendation to improve the physical stability of parenteral nutrition (PN) admixtures, 29 a reduction of the phosphatidylcholine content of emulsions for IV use may contribute to risk prevention of fat embolism. Therefore, flow cytometric monitoring of the CRP-lipid droplets might be useful for early diagnosis of fat embolism syndrome.…”